Kidialyte

Magnesium chloride hexahydrate, potassium chloride, sodium chloride, calcium chloride dihydrate and glucose, the active ingredients in Kidialyte, are an electrolyte solution presented as an intravenous solution for intravenous use. It restores fluid and electrolyte balance in patients with dehydration, electrolyte disturbances or requiring fluid resuscitation.

GNH USA supplies Kidialyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidialyte is an intravenous electrolyte solution used in conditions that involve fluid loss or electrolyte imbalance.

- Electrolyte replacement: repletes magnesium, potassium, sodium, calcium and glucose to correct deficiencies. - Fluid resuscitation: expands extracellular fluid volume in hypovolemic patients. - Hypokalemia: provides potassium to raise serum potassium levels. - Hypomagnesemia: supplies magnesium to normalize serum magnesium. - Hypocalcemia: delivers calcium for patients with low calcium. - Dehydration: restores both volume and essential electrolytes.

Kidialyte may cause adverse reactions related to its electrolyte composition and intravenous administration.

Common Side Effects: - Infusion site irritation or pain. - Mild hypernatremia. - Mild hyperkalemia. - Mild hypermagnesemia. - Transient hypotension. - Nausea or vomiting.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Severe hypermagnesemia causing respiratory depression. - Anaphylactic or severe allergic reaction. - Pulmonary edema from fluid overload. - Life‑threatening electrolyte imbalance. - Cardiac arrest.

Kidialyte should be administered with careful monitoring of electrolyte status and fluid balance.

- Assess baseline electrolytes: obtain serum levels before infusion. - Monitor cardiac function: watch for arrhythmias during and after administration. - Adjust infusion rate: tailor to patient’s volume status and renal function. - Avoid concurrent high‑dose potassium or magnesium agents: reduce risk of overdose. - Use aseptic technique: prevent contamination of the IV solution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Kidialyte can interact with other medications that affect electrolyte balance or fluid status.

Major Interactions (Avoid): - ACE inhibitors, ARBs or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Magnesium‑containing laxatives or antacids: increase risk of hypermagnesemia. - High‑dose calcium supplements: can lead to hypercalcemia.

Moderate Interactions (Monitor Closely): - Other intravenous fluids (e.g., normal saline): may cause fluid overload. - Loop diuretics: may exacerbate electrolyte shifts. - Blood products: monitor for electrolyte disturbances during transfusion.